COYA – coya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD) [Yahoo! Finance]
Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)
Coya Therapeutics, Inc. (NASDAQ: COYA) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $15.00 price target on the stock.
Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference
Form EFFECT Coya Therapeutics, Inc.
Form 424B3 Coya Therapeutics, Inc.
Form S-3 Coya Therapeutics, Inc.
Form 4 Coya Therapeutics, Inc. For: Nov 14 Filed by: SNYDER DAVID S
Form 4 Coya Therapeutics, Inc. For: Nov 13 Filed by: Swaminathan Arun
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.